← Open Payments lookup

SUSAN DRYMALSKI: Open Payments

NPI 1063442093 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$381 in 28 payments from 6 companies in 2025. Trend: 2023 $277 · 2024 $283 · 2025 $381

Food & beverage: $381
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.21$263
E.R. Squibb & Sons, L.L.C.3$61
Takeda Pharmaceuticals U.S.A., Inc.1$15
Teva Pharmaceuticals USA, Inc.1$14
Axsome Therapeutics, Inc.1$14
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$14

Products named: FANAPT, COBENFY, HETLIOZ, TRINTELLIX, AUSTEDO XR, Auvelity, CAPLYTA.

Industry payments across NV — which companies pay providers there.